NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 147 filers reported holding NATERA INC in Q3 2018. The put-call ratio across all filers is 0.10 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $821,000 | -49.2% | 7,364 | -48.3% | 0.00% | -60.0% |
| Q2 2021 | $1,617,000 | +145.0% | 14,235 | +119.0% | 0.01% | +150.0% |
| Q1 2021 | $660,000 | -75.5% | 6,500 | -76.0% | 0.00% | -66.7% |
| Q4 2020 | $2,697,000 | +7.3% | 27,100 | -22.1% | 0.01% | 0.0% |
| Q3 2020 | $2,514,000 | +758.0% | 34,800 | +493.5% | 0.01% | +500.0% |
| Q2 2020 | $293,000 | +10.2% | 5,864 | -34.1% | 0.00% | -50.0% |
| Q1 2020 | $266,000 | -38.7% | 8,900 | -31.0% | 0.00% | 0.0% |
| Q4 2019 | $434,000 | +81.6% | 12,890 | +76.7% | 0.00% | +100.0% |
| Q3 2019 | $239,000 | -42.8% | 7,295 | -58.1% | 0.00% | -50.0% |
| Q3 2018 | $418,000 | – | 17,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |